MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - mnc pharma
- PROCTER & GAMBLE HEALTH - MYLAN (US)
PROCTER & GAMBLE HEALTH vs MYLAN (US) - Comparison Results
PROCTER & GAMBLE HEALTH Change
Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More
MYLAN (US)
Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More
Financials
 PROCTER & GAMBLE HEALTH  MYLAN |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| PROCTER & GAMBLE HEALTH Dec-18 |
MYLAN Dec-18 |
PROCTER & GAMBLE HEALTH/ MYLAN |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 3,549 | 3,470 | - | |
| Low | Rs | 1,301 | 1,910 | - | |
| Sales per share (Unadj.) | Rs | 511.4 | 1,596.7 | - | |
| Earnings per share (Unadj.) | Rs | 61.3 | 43.4 | - | |
| Cash flow per share (Unadj.) | Rs | 74.0 | 342.3 | - | |
| Dividends per share (Unadj.) | Rs | 440.00 | 0 | - | |
| Dividend yield (eoy) | % | 18.1 | 0 | - | |
| Book value per share (Unadj.) | Rs | 927.8 | 1,727.4 | - | |
| Shares outstanding (eoy) | m | 16.60 | 514.50 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 4.7 | 1.7 | 281.5% | |
| Avg P/E ratio | x | 39.6 | 62.0 | 63.8% | |
| P/CF ratio (eoy) | x | 32.8 | 7.9 | 417.0% | |
| Price / Book Value ratio | x | 2.6 | 1.6 | 167.9% | |
| Dividend payout | % | 717.9 | 0 | - | |
| Avg Mkt Cap | Rs m | 40,257 | 1,384,010 | 2.9% | |
| No. of employees | `000 | 1.1 | 35.0 | 3.2% | |
| Total wages/salary | Rs m | 1,313 | 0 | - | |
| Avg. sales/employee | Rs Th | 7,486.7 | 23,471.7 | 31.9% | |
| Avg. wages/employee | Rs Th | 1,157.6 | 0 | - | |
| Avg. net profit/employee | Rs Th | 897.2 | 637.4 | 140.8% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 8,490 | 821,510 | 1.0% | |
| Other income | Rs m | 244 | 0 | - | |
| Total revenues | Rs m | 8,734 | 821,510 | 1.1% | |
| Gross profit | Rs m | 1,482 | 212,576 | 0.7% | |
| Depreciation | Rs m | 211 | 153,819 | 0.1% | |
| Interest | Rs m | 0 | 39,512 | 0.0% | |
| Profit before tax | Rs m | 1,514 | 19,246 | 7.9% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 66 | 0 | - | |
| Tax | Rs m | 563 | -3,062 | -18.4% | |
| Profit after tax | Rs m | 1,017 | 22,307 | 4.6% | |
| Gross profit margin | % | 17.5 | 25.9 | 67.4% | |
| Effective tax rate | % | 37.1 | -15.9 | -233.5% | |
| Net profit margin | % | 12.0 | 2.7 | 441.3% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 15,343 | 458,731 | 3.3% | |
| Current liabilities | Rs m | 1,960 | 334,465 | 0.6% | |
| Net working cap to sales | % | 157.6 | 15.1 | 1,042.1% | |
| Current ratio | x | 7.8 | 1.4 | 570.7% | |
| Inventory Days | Days | 49 | 84 | 58.3% | |
| Debtors Days | Days | 28 | 93 | 30.5% | |
| Net fixed assets | Rs m | 1,209 | 159,359 | 0.8% | |
| Share capital | Rs m | 166 | 437 | 38.0% | |
| Net worth | Rs m | 15,401 | 888,724 | 1.7% | |
| Long term debt | Rs m | 0 | 959,218 | 0.0% | |
| Total assets | Rs m | 17,595 | 2,383,903 | 0.7% | |
| Interest coverage | x | NM | 1.5 | - | |
| Debt to equity ratio | x | 0 | 1.1 | 0.0% | |
| Sales to assets ratio | x | 0.5 | 0.3 | 140.0% | |
| Return on assets | % | 5.8 | 2.6 | 223.0% | |
| Return on equity | % | 6.6 | 2.5 | 263.2% | |
| Return on capital | % | 10.3 | 3.2 | 322.6% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | -1,304 | 170,710 | -0.8% | |
| From Investments | Rs m | 12,697 | -88,238 | -14.4% | |
| From Financial Activity | Rs m | -301 | -79,527 | 0.4% | |
| Net Cashflow | Rs m | 11,093 | 1,414 | 784.4% | |
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 72.9 Rs / USD
Compare PROCTER & GAMBLE HEALTH With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Compare PROCTER & GAMBLE HEALTH With: PIRAMAL ENTERPRISES GLENMARK PHARMA CADILA HEALTHCARE DR. REDDYS LAB VENUS REMEDIES
Today's Market
A Time Correction in the Nifty(Momentum Moves)
The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.
Related Views On News
PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)
Aug 31, 2020 | Updated on Aug 31, 2020For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)
Nov 14, 2019 | Updated on Nov 14, 2019For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.
PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)
Aug 8, 2019 | Updated on Aug 8, 2019Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.
More Views on NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)
Feb 23, 2021An Indian company founded three decades ago in a garage caught my attention...
Gold 65,000 and Silver 84,000 in 2022
Feb 26, 2021In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More
